| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(78)90148-4 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0092867478901484?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0092867478901484?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 620421 |
| P2093 | author name string | N. Jones | |
| T. Shenk | |||
| P2860 | cites work | Isolation of Temperature-sensitive Mutants of Adenovirus Type 5 | Q64383478 |
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
| Genetic analysis of adenovirus type 2. I. Isolation and genetic characterization of temperature-sensitive mutants | Q36529377 | ||
| Reassociation of complementary strand-specific adenovirus type 2 DNA with viral DNA sequences of transformed cells | Q37505875 | ||
| A biochemical method for increasing the size of deletion mutations in simian virus 40 DNA | Q40085537 | ||
| The isolation and partial characterization of a new restriction endonuclease from Providencia stuartii | Q40577420 | ||
| Host-range mutants of adenovirus type 5 defective for growth in HeLa cells | Q43649487 | ||
| Location and identification of the genes for adenovirus type 2 early polypeptides | Q44677014 | ||
| Transcription of Simian virus 40. I. Separation of the strands of SV40 DNA and hybridization of the separated strands to RNA extracted from lytically infected and transformed cells | Q45820341 | ||
| Complementary strand-specific sequences from unique fragments of adenovirus type 2 DNA for hybridization-mapping experiments. | Q52892257 | ||
| Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome. | Q53597821 | ||
| Amount of viral DNA in the genome of cells transformed by adenovirus type 2 | Q53601747 | ||
| The infectivity of adenovirus 5 DNA-protein complex | Q64382358 | ||
| Physical mapping of temperature-sensitive mutations of adenoviruses | Q64382464 | ||
| A circular DNA—Protein complex from adenoviruses | Q64382851 | ||
| Isolation of conditional lethal mutants (temperature sensitive and host-dependent mutants) of adenovirus type 5 | Q64383103 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| viral genes | Q71237937 | ||
| P304 | page(s) | 181-8 | |
| P577 | publication date | 1978-01-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Isolation of deletion and substitution mutants of adenovirus type 5 | |
| P478 | volume | 13 |
| Q41436437 | A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor |
| Q44335171 | A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome |
| Q40428272 | A newly identified interaction between IVa2 and pVIII proteins during porcine adenovirus type 3 infection |
| Q24597439 | A polymerase chain resction mediated by a single primer: cloning of genomic adjacent to a serotonin receptor protein coding region |
| Q36919184 | A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication |
| Q40871252 | A simple method for the rapid generation of recombinant adenovirus vectors |
| Q36899563 | A thermolabile mutant of adenovirus 5 resulting from a substitution mutation in the protein VIII gene |
| Q36792140 | Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53 |
| Q24644862 | Acquisition of Host Cell DNA Sequences by Baculoviruses: Relationship Between Host DNA Insertions and FP Mutants of Autographa californica and Galleria mellonella Nuclear Polyhedrosis Viruses |
| Q64379647 | Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols |
| Q36549064 | Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1. |
| Q40594994 | Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. |
| Q38290833 | Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines |
| Q36859125 | Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression |
| Q41657050 | Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293) |
| Q39770682 | Adenovirus DNA: Structure and function of a novel replicon |
| Q36683439 | Adenovirus E1A protein activates transcription of the E1A gene subsequent to transcription complex formation |
| Q34468761 | Adenovirus E1A: remodelling the host cell, a life or death experience |
| Q36826114 | Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs. |
| Q35880562 | Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes |
| Q36655478 | Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. |
| Q36702372 | Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers |
| Q24643689 | Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells |
| Q35868511 | Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. |
| Q36851240 | Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff |
| Q38655771 | Adenovirus proteins and MHC expression. |
| Q35140327 | Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation |
| Q43163170 | Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. |
| Q36351624 | Adenovirus tumor-specific transplantation antigen is a function of the E1A early region |
| Q43765820 | Adenovirus type 5 E3 gene products interfere with the expression of the cytolytic T cell immunodominant E1 a antigen |
| Q39814449 | Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX |
| Q35228887 | Adenovirus-Based Expression Vectors and Recombinant Vaccines |
| Q39861470 | Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo |
| Q40524547 | Advances in cancer gene therapy |
| Q35241833 | Alterations to controls of cellular DNA synthesis by adenovirus infection |
| Q40850946 | Ammonium sulphate precipitation of recombinant adenovirus from culture medium: an easy method to increase the total virus yield |
| Q37338696 | An adenovirus type 5 early gene function regulates expression of other early viral genes |
| Q39581575 | An adenovirus type 5 mutant with the preterminal protein gene deleted efficiently provides helper functions for the production of recombinant adeno-associated virus |
| Q33813486 | An arginine-faced amphipathic alpha helix is required for adenovirus type 5 e4orf6 protein function |
| Q72938450 | An examination of adenovirus type 5 mutants for their ability to induce group C adenovirus tumor-specific transplantation antigenicity in rats |
| Q36884829 | Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells |
| Q37048872 | Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene |
| Q69849296 | Characterization of the genome of a vaccine strain of canine adenovirus type 1 |
| Q41859604 | Characterization of the recombinant adenovirus vector AdYB-1: implications for oncolytic vector development |
| Q37403590 | Codon insertion mutants of the adenovirus terminal protein |
| Q34725017 | Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas |
| Q36918636 | Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen |
| Q36901975 | Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome |
| Q33940203 | Covalently closed circles of human adenovirus DNA are infectious. |
| Q36178513 | Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines |
| Q45791814 | Deletion mutants of adenovirus 2: Isolation and initial characterization of virus carrying mutations near the right end of the viral genome |
| Q36896010 | Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA |
| Q37492831 | Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background |
| Q42514696 | Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets. |
| Q34769662 | Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses |
| Q36854089 | E1A and E1B proteins inhibit inflammation induced by adenovirus |
| Q36762683 | E2F from adenovirus-infected cells binds cooperatively to DNA containing two properly oriented and spaced recognition sites |
| Q37110666 | E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus |
| Q34328375 | E4orf6 variants with separate abilities to augment adenovirus replication and direct nuclear localization of the E1B 55-kilodalton protein |
| Q64377203 | Effect of adenovirus infection on transgene expression under the adenoviral MLP/TPL and the CMVie promoter/enhancer in CHO cells |
| Q40481068 | Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer. |
| Q32082734 | Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex |
| Q33557797 | Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome |
| Q35840357 | Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase. |
| Q64381318 | Evolutionary variants of mouse adenovirus containing cellular DNA sequences |
| Q37547077 | Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma |
| Q48397388 | Functional analysis of the nucleotide sequence surrounding the cap site for adenovirus type 5 region E1A messenger RNAs |
| Q33904270 | Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer |
| Q35686623 | Generation of adenovirus by transfection of plasmids |
| Q34113734 | Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus |
| Q36597290 | Hinf family: a novel repeated DNA family of the human genome |
| Q45798975 | Homology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA |
| Q35076737 | Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity |
| Q39606511 | Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes |
| Q36825617 | Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses |
| Q41142106 | Improved production of recombinant AAV by transient transfection of NB324K cells using electroporation |
| Q36916415 | Independent mutations in Ad2ts111 cause degradation of cellular DNA and defective viral DNA replication |
| Q40274958 | Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. |
| Q39686844 | Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex |
| Q45353698 | Investigations of virus-protozoa relationships in the model of the free-living ciliate Tetrahymena pyriformis and adenovirus type 3. |
| Q64381710 | Isolation and characterization of a viable deletion mutant of adenovirus type 3 |
| Q36688105 | Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein |
| Q42280576 | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain |
| Q35343757 | Method for introducing site-specific mutations into adenovirus 2 genome: construction of a small deletion mutant in VA-RNAI gene |
| Q41300792 | Molecular basis of immune evasion strategies by adenoviruses |
| Q37249720 | Negative-strand RNA viruses: genetic engineering and applications |
| Q59074474 | Normal human tissues contain RNA and antigens related to infectious adenovirus type 2 |
| Q36653293 | Packaging capacity and stability of human adenovirus type 5 vectors. |
| Q64380639 | Polarity in adenovirus recombination |
| Q39642143 | Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted |
| Q34085243 | Production of first generation adenovirus vectors: a review |
| Q38109356 | Prospects for oral replicating adenovirus-vectored vaccines |
| Q33929212 | Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes |
| Q34157687 | Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection |
| Q34636530 | Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters |
| Q36941297 | Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome |
| Q64381122 | Restriction maps of human adenovirus types 2, 5 and 3 for BclI, ClaI, PvuI and SphI endonucleases |
| Q33741620 | Role of early genes in pathogenesis of adenovirus pneumonia |
| Q33858906 | Role of early region 3 (E3) in pathogenesis of adenovirus disease |
| Q33649728 | Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication |
| Q36951763 | Sequence-independent autoregulation of the adenovirus type 5 E1A transcription unit |
| Q41455629 | Shuffling adenovirus promoters: a viral recombinant with early region 1A under late transcriptional control. |
| Q34741058 | Sirtuins are evolutionarily conserved viral restriction factors |
| Q36300185 | Stimulation of Xenopus oocyte protein synthesis by microinjected adenovirus RNA |
| Q36797205 | The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor |
| Q40064866 | The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells |
| Q38880684 | The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K. |
| Q35015433 | The RB-E2F1 pathway regulates autophagy. |
| Q35873937 | The a sequence is dispensable for isomerization of the herpes simplex virus type 1 genome |
| Q36806116 | The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. |
| Q36681830 | The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells |
| Q39874304 | The complete DNA sequence and genomic organization of the avian adenovirus CELO. |
| Q35875344 | The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle |
| Q41556393 | The genetic analysis of adenovirus recombination intriparental and superinfection crosses |
| Q64381033 | The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments |
| Q39106880 | The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53. |
| Q39782448 | Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator |
| Q39635479 | Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α |
| Q40144607 | Transformation-defective mutant of adenovirus type 5 containing a single altered E1a mRNA species |
| Q36921014 | Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B. |
| Q32023467 | Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments |
| Q40571045 | Use of recombinant adenovirus for metabolic engineering of mammalian cells. |
| Q38341549 | Use of site-directed mutagenesis to generate a herpes simplex virus type 1 strain 17+ mutant lacking seven HindIII restriction endonuclease cleavage sites |
| Q64381499 | Viable variants in VA-RNAI gene of an Ad2-Ad5 recombinant |
| Q43546899 | Viral delivery of recombinant short hairpin RNAs |
| Q35238178 | Virus-associated RNAs of naturally occurring strains and variants of group C adenoviruses |
| Q40358341 | p53 promotes adenoviral replication and increases late viral gene expression |
| Q33785919 | p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection |
Search more.